AXIN2 and pancreatic neoplasm: In pancreatic cancer, exosomal tRF-19-PNR8YPJZ derived from pluripotent stem cells (PSC) targets AXIN2 in pancreatic cancer cells, reducing its expression and thereby activating the Wnt signaling pathway, which promotes tumor proliferation and metastasis.42